Drug Shortage Report for ACYCLOVIR SODIUM INJECTION

Last updated on 2020-09-24 History
Report ID 118969
Drug Identification Number 02236916
Brand name ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ACYCLOVIR
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20mL vial
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-06-25
Estimated end date
Actual end date 2020-09-23
Shortage status Resolved
Updated date 2020-09-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-09-24 English Compare
v5 2020-09-23 French Compare
v4 2020-09-23 English Compare
v3 2020-06-26 English Compare
v2 2020-06-25 French Compare
v1 2020-06-25 English Compare

Showing 1 to 6 of 6